{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T02:20:26Z","timestamp":1793154026256,"version":"4.5.0"},"reference-count":46,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,1,15]],"date-time":"2025-01-15T00:00:00Z","timestamp":1736899200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Non-alcoholic fatty liver disease (NAFLD) or metabolic dysfunction-associated steatotic liver disease (MASLD) is closely associated with chronic inflammation and lipid metabolism disorders. The neutrophil-to-high-density lipoprotein cholesterol ratio (NHR) is an integrative marker reflecting inflammatory responses and lipid metabolism disorders and is associated with various diseases. This cross-sectional study aimed to determine the association between NHR and NAFLD, MASLD, and liver fibrosis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Data for this study were obtained from the 2017\u20132020 National Health and Nutrition Examination Survey (NHANES), we employed weighted multiple regression and restricted cubic spline (RCS) analysis to assess the relationship between NHR and NAFLD, MASLD, and liver fibrosis. Additionally, we performed stratified analyses based on gender, age, body mass index, diabetes, hypertension, smoking status, and history of cardiovascular disease to evaluate the consistency of these associations across different subgroups.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      A total of 6,526 participants were included in the study. 2,839 (weighted 44.1%) participants were diagnosed with NAFLD and 2,813 (weighted 43.7%) participants were diagnosed with MASLD. After adjusting for confounders, NHR was positively associated with the risk of NAFLD\/MASLD, and the correlation was particularly significant in the subgroups of females, those without hypertension, and those without diabetes (\n                      <jats:italic>p<\/jats:italic>\n                      \u202f&amp;lt;\u202f0.05). By the NHR quartile, the risk of NAFLD\/MASLD increased progressively with higher NHR levels (P for trend &amp;lt;0.001). In addition, RCS analysis showed a nonlinear association between NHR and NAFLD\/MASLD and liver fibrosis (P-non-linear &amp;lt;0.05).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>NHR may serve as a potential marker for NAFLD\/MASLD and liver fibrosis, and lowering NHR levels could help reduce the incidence of these conditions.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fmed.2024.1491858","type":"journal-article","created":{"date-parts":[[2025,1,15]],"date-time":"2025-01-15T01:11:37Z","timestamp":1736903497000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":17,"title":["Association between neutrophil-to-high-density lipoprotein cholesterol ratio and non-alcoholic fatty liver disease or metabolic dysfunction-associated steatotic liver disease: evidence from NHANES 2017\u20132020"],"prefix":"10.3389","volume":"11","author":[{"given":"Na","family":"Zhu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanyan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingying","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"XinYu","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,1,15]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1016\/j.eprac.2022.03.010","article-title":"American Association of Clinical Endocrinology Clinical Practice Guideline for the diagnosis and Management of Nonalcoholic Fatty Liver Disease in primary care and endocrinology clinical settings: co-sponsored by the American Association for the Study of Liver Diseases (AASLD)","volume":"28","author":"Cusi","year":"2022","journal-title":"Endocr Pract"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1016\/S2468-1253(22)00165-0","article-title":"The prevalence and incidence of NAFLD worldwide: a systematic review and meta-analysis","volume":"7","author":"Riazi","year":"2022","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"1966","DOI":"10.1097\/HEP.0000000000000520","article-title":"A multisociety Delphi consensus statement on new fatty liver disease nomenclature","volume":"78","author":"Rinella","year":"2023","journal-title":"Hepatology"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1038\/s41591-018-0104-9","article-title":"Mechanisms of NAFLD development and therapeutic strategies","volume":"24","author":"Friedman","year":"2018","journal-title":"Nat Med"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"1375","DOI":"10.1136\/gutjnl-2020-322786","article-title":"Mortality in biopsy-confirmed nonalcoholic fatty liver disease","volume":"70","author":"Simon","year":"2021","journal-title":"Gut"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"1691","DOI":"10.1136\/gutjnl-2020-320622","article-title":"NAFLD and increased risk of cardiovascular disease: clinical associations, pathophysiological mechanisms and pharmacological implications","volume":"69","author":"Targher","year":"2020","journal-title":"Gut"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"597648","DOI":"10.3389\/fendo.2020.597648","article-title":"Chronic inflammation in non-alcoholic Steatohepatitis: molecular mechanisms and therapeutic strategies","volume":"11","author":"Luci","year":"2020","journal-title":"Front Endocrinol"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1038\/s41423-021-00832-3","article-title":"Neutrophils in chronic inflammatory diseases","volume":"19","author":"Herrero-Cervera","year":"2022","journal-title":"Cell Mol Immunol"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"4570219","DOI":"10.1155\/2020\/4570219","article-title":"Circulating neutrophils of nonalcoholic Steatohepatitis patients show an activated phenotype and suppress T lymphocytes activity","volume":"2020","author":"Antonucci","year":"2020","journal-title":"J Immunol Res"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1186\/s13098-021-00741-5","article-title":"Association of anti-oxidative capacity of HDL with subclinical atherosclerosis in subjects with and without non-alcoholic fatty liver disease","volume":"13","author":"Karami","year":"2021","journal-title":"Diabetol Metab Syndr"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"101092","DOI":"10.1016\/j.molmet.2020.101092","article-title":"Dysregulated lipid metabolism links NAFLD to cardiovascular disease","volume":"42","author":"Deprince","year":"2020","journal-title":"Mol Metab"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"1127134","DOI":"10.3389\/fendo.2023.1127134","article-title":"Correlation of multiple lipid and lipoprotein ratios with nonalcoholic fatty liver disease in patients with newly diagnosed type 2 diabetic mellitus: a retrospective study","volume":"14","author":"Li","year":"2023","journal-title":"Front Endocrinol"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1186\/s12872-020-01771-z","article-title":"Relationship between neutrophils to HDL-C ratio and severity of coronary stenosis","volume":"21","author":"Kou","year":"2021","journal-title":"BMC Cardiovasc Disord"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"597","DOI":"10.2147\/DMSO.S238990","article-title":"Comparison of the value of neutrophil to high-density lipoprotein cholesterol ratio and lymphocyte to high-density lipoprotein cholesterol ratio for predicting metabolic syndrome among a population in the southern coast of China","volume":"13","author":"Chen","year":"2020","journal-title":"Diabetes Metab Syndr Obes"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"1127913","DOI":"10.3389\/fnut.2023.1127913","article-title":"Neutrophil-to-high-density-lipoprotein-cholesterol ratio and mortality among patients with hepatocellular carcinoma","volume":"10","author":"Shi","year":"2023","journal-title":"Front Nutr"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1186\/s12944-021-01462-4","article-title":"Compared with the monocyte to high-density lipoprotein ratio (MHR) and the neutrophil to lymphocyte ratio (NLR), the neutrophil to high-density lipoprotein ratio (NHR) is more valuable for assessing the inflammatory process in Parkinson\u2019s disease","volume":"20","author":"Liu","year":"2021","journal-title":"Lipids Health Dis"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"925690","DOI":"10.3389\/fimmu.2022.925690","article-title":"Association between SII and hepatic steatosis and liver fibrosis: a population-based study","volume":"13","author":"Xie","year":"2022","journal-title":"Front Immunol"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"857110","DOI":"10.3389\/fendo.2022.857110","article-title":"Relationship between non-alcoholic fatty liver disease and degree of hepatic steatosis and bone mineral density","volume":"13","author":"Xie","year":"2022","journal-title":"Front Endocrinol"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"1717","DOI":"10.1053\/j.gastro.2019.01.042","article-title":"Accuracy of FibroScan controlled attenuation parameter and liver stiffness measurement in assessing steatosis and fibrosis in patients with nonalcoholic fatty liver disease","volume":"156","author":"Eddowes","year":"2019","journal-title":"Gastroenterology"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"2597","DOI":"10.2147\/DMSO.S464406","article-title":"The association between neutrophil\/high-density lipoprotein cholesterol ratio and non-alcoholic fatty liver disease in a healthy population","volume":"17","author":"Jia","year":"2024","journal-title":"Diabetes Metab Syndr Obes"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1016\/j.jhep.2021.04.044","article-title":"Diagnostic accuracy of elastography and magnetic resonance imaging in patients with NAFLD: a systematic review and meta-analysis","volume":"75","author":"Selvaraj","year":"2021","journal-title":"J Hepatol"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1016\/j.jhep.2021.12.031","article-title":"Non-invasive tests accurately stratify patients with NAFLD based on their risk of liver-related events","volume":"76","author":"Boursier","year":"2022","journal-title":"J Hepatol"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1007\/s00018-018-2947-0","article-title":"Molecular pathways of nonalcoholic fatty liver disease development and progression","volume":"76","author":"Bessone","year":"2018","journal-title":"Cell Mol Life Sci"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1186\/s12916-023-02793-y","article-title":"Associations between an inflammatory diet index and severe non-alcoholic fatty liver disease: a prospective study of 171,544 UK biobank participants","volume":"21","author":"Petermann-Rocha","year":"2023","journal-title":"BMC Med"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"1389967","DOI":"10.3389\/fimmu.2024.1389967","article-title":"Associations between systemic inflammation indicators and nonalcoholic fatty liver disease: evidence from a prospective study","volume":"15","author":"Gong","year":"2024","journal-title":"Front Immunol"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"2511","DOI":"10.3390\/cells11162511","article-title":"Endothelial cell dysfunction and nonalcoholic fatty liver disease (NAFLD): a concise review","volume":"11","author":"Nasiri-Ansari","year":"2022","journal-title":"Cells"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"1892","DOI":"10.3390\/nu15081892","article-title":"Predictive role of neutrophil-percentage-to-albumin ratio (NPAR) in nonalcoholic fatty liver disease and advanced liver fibrosis in nondiabetic US adults: evidence from NHANES 2017\u20132018","volume":"15","author":"Liu","year":"2023","journal-title":"Nutrients"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"751802","DOI":"10.3389\/fendo.2021.751802","article-title":"Role of neutrophils in the pathogenesis of nonalcoholic Steatohepatitis","volume":"12","author":"Hwang","year":"2021","journal-title":"Front Endocrinol"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1038\/nri3024","article-title":"Neutrophils in the activation and regulation of innate and adaptive immunity","volume":"11","author":"Mantovani","year":"2011","journal-title":"Nat Rev Immunol"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1016\/j.immuni.2010.11.011","article-title":"Neutrophils, from marrow to microbes","volume":"33","author":"Borregaard","year":"2010","journal-title":"Immunity"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"1333","DOI":"10.1161\/ATVBAHA.111.226258","article-title":"Neutrophil activation is attenuated by high-density lipoprotein and Apolipoprotein A-I in in vitro and in vivo models of inflammation","volume":"31","author":"Murphy","year":"2011","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1016\/j.bbalip.2014.11.010","article-title":"Neutrophil effector responses are suppressed by secretory phospholipase A2 modified HDL","volume":"1851","author":"Curcic","year":"2015","journal-title":"Biochim Biophys Acta"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1186\/s12944-020-01238-2","article-title":"Neutrophil to high-density lipoprotein ratio has a superior prognostic value in elderly patients with acute myocardial infarction: a comparison study","volume":"19","author":"Huang","year":"2020","journal-title":"Lipids Health Dis"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1007\/s12020-017-1323-4","article-title":"Neutrophil depletion improves diet-induced non-alcoholic fatty liver disease in mice","volume":"57","author":"Ou","year":"2017","journal-title":"Endocrine"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.3390\/biomedicines12051105","article-title":"Circulating neutrophil profiles undergo a dynamic shift during metabolic dysfunction-associated Steatohepatitis (MASH) progression","volume":"12","author":"Maretti-Mira","year":"2024","journal-title":"Biomedicines"},{"key":"ref36","doi-asserted-by":"publisher","first-page":"1407","DOI":"10.1038\/nm.2885","article-title":"Neutrophils mediate insulin resistance in high fat diet fed mice via secreted elastase","volume":"18","author":"Talukdar","year":"2012","journal-title":"Nat Med"},{"key":"ref37","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/s10020-019-0084-3","article-title":"Increased proteinase 3 and neutrophil elastase plasma concentrations are associated with non-alcoholic fatty liver disease (NAFLD) and type 2 diabetes","volume":"25","author":"Mirea","year":"2019","journal-title":"Mol Med"},{"key":"ref38","doi-asserted-by":"publisher","first-page":"202","DOI":"10.2119\/molmed.2016.00033","article-title":"Activation of proteinase 3 contributes to nonalcoholic fatty liver disease and insulin resistance","volume":"22","author":"Toonen","year":"2016","journal-title":"Mol Med"},{"key":"ref39","doi-asserted-by":"publisher","first-page":"1255","DOI":"10.1089\/ars.2014.6108","article-title":"Myeloperoxidase\u2013hepatocyte\u2013stellate cell cross talk promotes hepatocyte injury and fibrosis in experimental nonalcoholic Steatohepatitis","volume":"23","author":"Pulli","year":"2015","journal-title":"Antioxid Redox Signal"},{"key":"ref40","doi-asserted-by":"publisher","first-page":"1259","DOI":"10.3390\/cells8101259","article-title":"Potential therapeutic application of estrogen in gender disparity of nonalcoholic fatty liver disease\/nonalcoholic Steatohepatitis","volume":"8","author":"Lee","year":"2019","journal-title":"Cells"},{"key":"ref41","doi-asserted-by":"publisher","first-page":"1406","DOI":"10.1002\/hep.26761","article-title":"Gender and menopause impact severity of fibrosis among patients with nonalcoholic Steatohepatitis","volume":"59","author":"Yang","year":"2014","journal-title":"Hepatology"},{"key":"ref42","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1097\/CM9.0000000000002753","article-title":"Hypertension and NAFLD risk: insights from the NHANES 2017\u20132018 and Mendelian randomization analyses","volume":"137","author":"Yuan","year":"2023","journal-title":"Chin Med J"},{"key":"ref43","doi-asserted-by":"publisher","first-page":"e002243","DOI":"10.1136\/bmjdrc-2021-002243","article-title":"Variables associated with increased incidence of non-alcoholic fatty liver disease (NAFLD) in patients with type 2 diabetes","volume":"9","author":"Loosen","year":"2021","journal-title":"BMJ Open Diabetes Res Care"},{"key":"ref44","doi-asserted-by":"publisher","first-page":"2195203","DOI":"10.1080\/07853890.2023.2195203","article-title":"Association between dietary inflammation index and hypertension in participants with different degrees of liver steatosis","volume":"55","author":"Wu","year":"2023","journal-title":"Ann Med"},{"key":"ref45","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.immuni.2021.12.013","article-title":"Inflammation in obesity, diabetes and related disorders","volume":"55","author":"Rohm","year":"2022","journal-title":"Immunity"},{"key":"ref46","doi-asserted-by":"publisher","first-page":"1290","DOI":"10.1053\/j.gastro.2020.06.006","article-title":"Bariatric surgery provides long-term resolution of nonalcoholic Steatohepatitis and regression of fibrosis","volume":"159","author":"Lassailly","year":"2020","journal-title":"Gastroenterology"}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2024.1491858\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,15]],"date-time":"2025-01-15T01:11:42Z","timestamp":1736903502000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2024.1491858\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,15]]},"references-count":46,"alternative-id":["10.3389\/fmed.2024.1491858"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2024.1491858","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,15]]},"article-number":"1491858"}}